Related Experiment Video
Updated: Jan 11, 2026
09:57
Examining Proteasome Assembly with Recombinant Archaeal Proteasomes and Nondenaturing PAGE: The Case for a Combined Approach
Published on: December 17, 2016
7.0K
Small molecule proteasome activation: comparative structural analysis of known stimulators.
Jaida M Osman1, Darci J Trader2
1Department of Chemistry, University of California, Irvine, CA 92617, United States.
Bioorganic & Medicinal Chemistry
|November 12, 2025
Summary
Proteasome activity declines with age, disrupting cellular health. This review analyzes known proteasome stimulators to guide the development of new therapies for age-related diseases and enhance cellular health span.
Area of Science:
- Biochemistry
- Cell Biology
- Molecular Medicine
Background:
- The proteasome is crucial for protein degradation in eukaryotic cells.
- Declining proteasome activity with age leads to proteostasis disruption and disease.
- Enhancing proteasome activity may improve cellular health span and treat diseases.
Purpose of the Study:
- To review and analyze the structural features of known proteasome stimulators.
- To identify trends and key structural motifs for developing more potent activators.
- To advance understanding of proteasome stimulation for therapeutic applications.
Main Methods:
- Literature review of existing proteasome stimulators.
- Structural analysis of identified compounds.
- Identification of common structural characteristics and trends.
Main Results:
- Current proteasome stimulators often repurposed from other therapeutic areas.
- Analysis reveals specific structural motifs associated with proteasome activation.
- Trends indicate potential for designing novel, more potent stimulators.
Conclusions:
- There is a significant need for novel small molecules specifically developed as proteasome activators.
- Understanding structure-activity relationships is key to designing effective proteasome stimulators.
- This analysis provides a foundation for developing new therapeutic strategies targeting proteasome function.
More Related Videos
07:22Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
Published on: January 12, 2024
4.4K
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
5.5K
Related Concept Videos
01:17The Proteasome Structure
1.6K
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
1.6K
00:49Ligand Binding and Linkage
5.4K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.4K
01:19Allosteric Proteins-ATCase
6.4K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.4K
02:18The Proteasome
10.0K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.0K
01:13The Proteasome
1.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
02:18The Proteasome
4.4K
4.4K